In a retrospective study on breast cancer patients with brain metastases [22], the median time from first recurrence to brain metastasis was determined to be 5.5 months for TNBC patients as compared to 9.6 months for HER2-overexpressing patients. The gene discussed is ERBB2; the disease is breast carcinoma.